TABLE 4.
Quality recommendations found in the review of existing guidelines
| Organization, year (reference) | Cecal intubation rate | Recommendations | WT (without polypectomy or biopsy) | ||
|---|---|---|---|---|---|
|
| |||||
| Screening | Symptomatic | ADR | PR | ||
| PEBC, 2007 (7) | 95% provided adequate preparation and no structural abnormalities | No recommendations | None | None | No recommendation |
| ASGE/ACG, 2007 (27) | 95% | 90% | Screening patients >50 years of age: 25% men 15% women | None | ≥6 min |
| CAG, 2008 (14) | 95% | 85%–90% | Screening in healthy asymptomatic patients >50 years: 25% men; 15% women | None | >7 min |
| European Commission, 2010 (8) | >90% acceptable, >95% desirable | None | None | No WT given, but recommended as an outcome to be monitored | |
| National Bowel Cancer Screening Program UK, 2011 (9) | 90% with no adjustment for poor bowel preparation or structural lesions | ≥35% in context of an FOBT-based screening program None | None | ≥6 min | |
| National Bowel Cancer Screening Program Australia, 2009 (2) | 95% | 90% | >20% in patients >50 years of age for initial colonoscopy | None | ≥6 min |
ADR Adenoma detection rate; ASGE/ACG American Society for Gastrointestinal Endoscopy/American College of Gastroenterologists; CAG Canadian Association for Gastroenterology; FOBT Fecal occult blood test; PEBC Program in Evidence-Based Care; PR Polypectomy rate; UK United Kingdom; WT Withdrawal time